Form 4 Tracker
Heather Raymon

SVP, Research and Development · 2 filings · Latest: May 19, 2026

Artiva Biotherapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ARTV
Heather RaymonSVP, Research and DevelopmentMay 19, 2026
Sale
$9.013,095$27.9K148,228
ARTV
Heather RaymonMay 18, 2026
Proposed Sale
$9.223,500$32.3K